Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Other Working Capital Changes (2020 - 2025)

Caribou Biosciences (CRBU) has disclosed Other Working Capital Changes for 6 consecutive years, with $724000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes rose 265.3% to $724000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$548000.0, a 5380.0% decrease, with the full-year FY2025 number at -$548000.0, down 5380.0% from a year prior.
  • Other Working Capital Changes was $724000.0 for Q4 2025 at Caribou Biosciences, up from $624000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $31.4 million in Q2 2021 to a low of -$29.0 million in Q3 2021.
  • A 5-year average of -$105150.0 and a median of -$293000.0 in 2023 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: plummeted 42794.12% in 2021, then soared 265.3% in 2025.
  • Caribou Biosciences' Other Working Capital Changes stood at -$2.4 million in 2021, then soared by 107.53% to $184000.0 in 2022, then plummeted by 1076.09% to -$1.8 million in 2023, then skyrocketed by 75.61% to -$438000.0 in 2024, then skyrocketed by 265.3% to $724000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRBU's Other Working Capital Changes are $724000.0 (Q4 2025), $624000.0 (Q3 2025), and -$1.6 million (Q2 2025).